We care about transforming health. We are committed to improving the health of patients by making our innovations available throughout the pharmaceutical value chain, licensing products based on value and project development needs. We offer innovative medicines, developed in compliance with ethical and good pharmaceutical practice regulations and applying the criteria established in the International Conference on Harmonisation (ICH) guidelines. Our products help to improve the lives of millions of patients worldwide every day.
Throughout the development phases of a new molecule, to guarantee the quality and safety of the work, we apply Good Laboratory Practices (GLP), Good Clinical Practices (GCP) & Good Manufacturing Practices (GMP), with consideration and respect for the environment at all times.
We are actively looking for partners to license our products. In line with our licensing strategy, we are also open to the possibility of licensing our products in earlier phases, after proof of concept (Phase IIa).